Annual CFO
-$20.60 M
+$16.77 M+44.88%
31 December 2023
Summary:
Eliem Therapeutics annual cash flow from operations is currently -$20.60 million, with the most recent change of +$16.77 million (+44.88%) on 31 December 2023. During the last 3 years, it has risen by +$15.47 million (+42.89%).ELYM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$7.55 M
-$6.89 M-1032.68%
30 September 2024
Summary:
Eliem Therapeutics quarterly cash flow from operations is currently -$7.55 million, with the most recent change of -$6.89 million (-1032.68%) on 30 September 2024. Over the past year, it has dropped by -$6.61 million (-697.78%).ELYM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$10.99 M
-$11.04 M-19377.19%
30 September 2024
Summary:
Eliem Therapeutics TTM cash flow from operations is currently -$10.99 million, with the most recent change of -$11.04 million (-19377.19%) on 30 September 2024. Over the past year, it has increased by +$9.61 million (+46.66%).ELYM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELYM Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -697.8% | +46.7% |
| 3 y3 years | +42.9% | +4.2% | +69.5% |
| 5 y5 years | -311.3% | - | - |
ELYM Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +311.3% | -316.5% | <-9999.0% |
Eliem Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.55 M(+1032.7%) | -$10.99 M(<-9900.0%) |
| June 2024 | - | -$667.00 K(-63.3%) | $57.00 K(-100.8%) |
| Mar 2024 | - | -$1.82 M(+92.1%) | -$7.24 M(-64.8%) |
| Dec 2023 | -$20.60 M(-44.9%) | -$947.00 K(-127.1%) | -$20.60 M(-26.7%) |
| Sept 2023 | - | $3.49 M(-143.8%) | -$28.10 M(-21.4%) |
| June 2023 | - | -$7.96 M(-47.5%) | -$35.77 M(-14.4%) |
| Mar 2023 | - | -$15.18 M(+79.6%) | -$41.77 M(+11.8%) |
| Dec 2022 | -$37.37 M | -$8.45 M(+102.4%) | -$37.37 M(+1.5%) |
| Sept 2022 | - | -$4.17 M(-70.1%) | -$36.80 M(-19.3%) |
| June 2022 | - | -$13.97 M(+29.6%) | -$45.60 M(+13.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$10.78 M(+36.7%) | -$40.11 M(+11.2%) |
| Dec 2021 | -$36.07 M(+155.9%) | -$7.88 M(-39.2%) | -$36.07 M(+6.7%) |
| Sept 2021 | - | -$12.97 M(+52.9%) | -$33.81 M(+45.6%) |
| June 2021 | - | -$8.48 M(+25.8%) | -$23.23 M(+25.5%) |
| Mar 2021 | - | -$6.74 M(+19.8%) | -$18.51 M(+31.3%) |
| Dec 2020 | -$14.10 M(+181.5%) | -$5.62 M(+136.2%) | -$14.10 M(+66.4%) |
| Sept 2020 | - | -$2.38 M(-36.8%) | -$8.47 M(+39.1%) |
| June 2020 | - | -$3.77 M(+62.1%) | -$6.09 M(+162.1%) |
| Mar 2020 | - | -$2.33 M | -$2.33 M |
| Dec 2019 | -$5.01 M | - | - |
FAQ
- What is Eliem Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Eliem Therapeutics?
- What is Eliem Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Eliem Therapeutics?
- What is Eliem Therapeutics quarterly CFO year-on-year change?
- What is Eliem Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Eliem Therapeutics?
- What is Eliem Therapeutics TTM CFO year-on-year change?
What is Eliem Therapeutics annual cash flow from operations?
The current annual CFO of ELYM is -$20.60 M
What is the all time high annual CFO for Eliem Therapeutics?
Eliem Therapeutics all-time high annual cash flow from operations is -$5.01 M
What is Eliem Therapeutics quarterly cash flow from operations?
The current quarterly CFO of ELYM is -$7.55 M
What is the all time high quarterly CFO for Eliem Therapeutics?
Eliem Therapeutics all-time high quarterly cash flow from operations is $3.49 M
What is Eliem Therapeutics quarterly CFO year-on-year change?
Over the past year, ELYM quarterly cash flow from operations has changed by -$6.61 M (-697.78%)
What is Eliem Therapeutics TTM cash flow from operations?
The current TTM CFO of ELYM is -$10.99 M
What is the all time high TTM CFO for Eliem Therapeutics?
Eliem Therapeutics all-time high TTM cash flow from operations is $57.00 K
What is Eliem Therapeutics TTM CFO year-on-year change?
Over the past year, ELYM TTM cash flow from operations has changed by +$9.61 M (+46.66%)